Ingevity reported record sales of $419.9 million, a 17.2% increase year-over-year. The company also announced two strategic growth investments: the acquisition of Ozark Materials and an investment in Nexeon Limited.
Record sales of $419.9 million, up 17.2% year-over-year, were achieved.
Net income reached $59.8 million, with diluted earnings per share (EPS) at $1.54; adjusted earnings were $67.0 million, and diluted adjusted EPS was $1.73.
The second-highest quarterly EBITDA was $121.1 million, a 2.9% increase, with an adjusted EBITDA margin of 28.8%.
Operating cash flow was $90.5 million, and free cash flow was $60.9 million.
Ingevity reaffirms its 2022 guidance ranges of sales between $1.525 billion to $1.65 billion and adjusted EBITDA between $430 million to $470 million.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance